NeoGenomics Holds Annual Stockholder Meeting

TL;DR

NEO shareholders voted on directors and auditors at the May 23rd meeting.

AI Summary

On May 23, 2024, NeoGenomics, Inc. filed an 8-K report to announce the results of its annual meeting of stockholders. The company's stockholders voted on several proposals, including the election of directors and the ratification of the appointment of its independent registered public accounting firm.

Why It Matters

This filing confirms the outcomes of key shareholder votes, providing clarity on the company's leadership and financial oversight.

Risk Assessment

Risk Level: low — This is a routine filing reporting on the results of a shareholder meeting, with no new material financial or operational information.

Key Players & Entities

• NeoGenomics, Inc. (company) — Registrant
• May 23, 2024 (date) — Date of earliest event reported
• Nevada (jurisdiction) — State of incorporation
• 74-2897368 (tax_id) — I.R.S. Employer Identification No.
• 9490 NeoGenomics Way, Fort Myers, Florida 33912 (address) — Address of principal executive offices
• (239) 768-0600 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.001 — ch registered: Common Stock, par value $0.001 per share NEO The Nasdaq Stock Market L

Filing Documents

• neo-20240523.htm (8-K) — 52KB
• 0001077183-24-000081.txt ( ) — 175KB
• neo-20240523.xsd (EX-101.SCH) — 2KB
• neo-20240523_lab.xml (EX-101.LAB) — 22KB
• neo-20240523_pre.xml (EX-101.PRE) — 13KB
• neo-20240523_htm.xml (XML) — 3KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On May 23, 2024, the Company held an annual meeting of its stockholders. At the annual meeting, 117,598,762 shares of the Company's common stock, par value $0.001 per share, were present or represented by proxy at the meeting, representing approximately 92.11% of the outstanding Voting Stock as of March 25, 2024, the record date for the annual meeting. At the annual meeting, four proposals were submitted for a vote of the Company's stockholders and the related results are as follows: (1) Proposal No. 1: The election of Lynn A. Tetrault, Christopher M. Smith, Dr. Alison L. Hannah, Stephen M. Kanovsky, Michael A. Kelly, David B. Perez, Anthony P. Zook, Elizabeth Floegel and Dr. Neil Gunn to serve as members of the Board of Directors until the next succeeding annual meeting of stockholders or until his or her successor has been duly elected and qualified. The stockholders elected the nine directors by the following votes: Votes For Votes Withheld Votes Against Broker Non-Votes Lynn A. Tetrault 83,003,873 27,070,660 — 7,524,229 Christopher M. Smith 109,124,682 949,851 — 7,524,229 Dr. Alison L. Hannah 107,190,288 2,884,245 — 7,524,229 Stephen M. Kanovsky 107,073,992 3,000,541 — 7,524,229 Michael A. Kelly 84,662,179 25,412,354 — 7,524,229 David B. Perez 109,230,796 843,737 — 7,524,229 Anthony P. Zook 108,543,639 1,530,894 — 7,524,229 Elizabeth Floegel 109,748,045 326,488 — 7,524,229 Dr. Neil Gunn 108,284,625 1,789,908 — 7,524,229 (2) Proposal No. 2: The approval, on an advisory basis, of the compensation paid to the Company's Named Executive Officers, as identified in the proxy statement for the annual meeting. The advisory approval received an affirmative vote of a majority of the votes cast by stockholders as follows: Number of Votes Outstanding % Voted % For 76,045,753 59.56% 69.54% Against 33,308,929 26.09% 30.45% Abstentions 719,851 0.56% 0.65% (3) Proposal No. 3: The approval of the

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEOGENOMICS, INC. Date: May 24, 2024 By: /s/ Alicia C. Olivo Alicia C. Olivo EVP, General Counsel & Business Development and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR